Colistimethate Sodium+Imipenem+Cilastatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Colistimethate Sodium+Imipenem+Cilastatin, covering 2018-10-19 to 2018-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) [Phase 3]